Aspire Biopharma is developing next generation absorption of medicine that will have a significant impact on the opioid crisis. Our nano technology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tract.

Aspire’s technology comes from a new mechanism of action (absorption pathway) which allows for instant absorption in the mouth. Benefits of “instant absorption” are to provide nearly instant treatment impact and also allows high dose absorption.

Our technology can be applied to any number of proven, approved, “do no harm” drugs and supplements, such as analgesics, erectile disfunction and traumatic brain injury drugs.